Clinical trial
Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression (R21)
NCT01896934 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression (R21)
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2013
- Completion date
- June 30, 2016
- Enrollment
- 31 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.